| Knight, Sara J |
| Active, not recruiting | N/A | 230 | US | Availability of contextual PGHD at the visit | VA Office of Research and Development, University of Utah | Pain | 09/25 | 09/25 | | |
| Beck, James D |
NCT04994015: Parkinson's Foundation PD GENEration Genetic Registry |
|
|
| Recruiting | N/A | 25000 | Canada, US, RoW | Lab Assay for seven genetic variants for Parkinson's Disease | Parkinson's Foundation, Indiana University, Fulgent Genetics, The Parkinson Study Group | Parkinson's Disease | 12/24 | 06/25 | | |
| Recruiting | N/A | 1000000 | US | Non-interventional | Parkinson's Foundation | Parkinson Disease | 12/30 | 12/30 | | |
| Wambaugh, Julie L |
| Active, not recruiting | 2 | 80 | US | SET (Speech Entrainment Therapy) 3 weeks, SET (Speech Entrainment Therapy) 4.5 weeks, SET (Speech Entrainment Therapy) 6 weeks, No Therapy 6 Weeks | Medical University of South Carolina, National Institute on Deafness and Other Communication Disorders (NIDCD) | Aphasia, Aphasia Non Fluent, Stroke | 05/24 | 10/25 | | |
| Colon-Emeric, Cathleen S |
| Completed | N/A | 297 | US | | Duke University, National Institute on Aging (NIA) | Resilience, Aging | 10/23 | 10/23 | | |
| Completed | N/A | 39 | US | Bone Health Service Model | VA Office of Research and Development | Osteoporosis, Osteopenia, Osteoporotic Fracture | 08/24 | 12/24 | | |
PRISM, NCT06304428: Prevention of Injury in Skilled Nursing Facilities Through Optimizing Medications |
|
|
| Not yet recruiting | N/A | 3780 | NA | Deprescribing Care Model, Bone Health Service Model, Injury Prevention Service Model | Duke University, Patient-Centered Outcomes Research Institute, Hebrew SeniorLife, Brown University, The American Health Care Association, University of North Carolina, Chapel Hill | Accidental Falls/Prevention and Control, Osteoporosis | 07/28 | 07/28 | | |
| White, Paul |
| Recruiting | N/A | 35 | US | Exercise training | VA Office of Research and Development | HFpEF | 07/27 | 02/28 | | |
| Recruiting | N/A | 300 | US | Mitoquinone, MitoQ, Placebo | VA Office of Research and Development | Long-COVID | 10/27 | 10/28 | | |
NCT05648630: Improving Exercise Rehabilitation Efficacy Outcomes Veterans Peripheral Artery Disease |
|
|
| Recruiting | N/A | 65 | US | PB125, Placebo, Exercise Rehabilitation | VA Office of Research and Development | Peripheral Artery Disease (D058729), Oxidative Stress (D018384), Inflammation (D007249) | 06/28 | 06/28 | | |
| Weir, Charlene Raye |
| Completed | N/A | 208 | US | Remote monitoring and predictive analytics, Sham comparator | VA Office of Research and Development, George E. Wahlen Department of Veterans Affairs Medical Center, Michael E. DeBakey VA Medical Center, VA Palo Alto Health Care System, Malcom Randall VA Medical Center, Hunter Holmes McGuire VA Medical Center, VHA Innovation Ecosystem | Heart Failure | 08/24 | 10/24 | | |
| Tuteja, Ashok K |
| Recruiting | 2 | 120 | US | Cal-Mag Butyrate, Bodybio Calcium Magnesium Butyrate, Placebo, Placebo Cal-Mag Butyrate | VA Office of Research and Development, Miami VA Healthcare System, VA Salt Lake City Health Care System | Gulf War Illness, Chronic Fatigue, Neurocognitive Dysfunction | 10/25 | 03/26 | | |
| Zickmund, Susan L |
| Completed | N/A | 208 | US | Remote monitoring and predictive analytics, Sham comparator | VA Office of Research and Development, George E. Wahlen Department of Veterans Affairs Medical Center, Michael E. DeBakey VA Medical Center, VA Palo Alto Health Care System, Malcom Randall VA Medical Center, Hunter Holmes McGuire VA Medical Center, VHA Innovation Ecosystem | Heart Failure | 08/24 | 10/24 | | |
| Renshaw, Perry F |
NCT03202095: Creatine for Treatment of Depression Associated With Type 2 Diabetes |
|
|
| Withdrawn | 4 | 15 | US | Creatine Monohydrate | University of Utah | Major Depressive Disorder | 06/24 | 06/24 | | |
NCT02192931: A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users |
|
|
| Completed | 4 | 66 | US | Creatine monohydrate | Perry Renshaw | Depression, Dual Diagnosis, Drug Addiction | 01/23 | 01/23 | | |
NCT06506253: Massage for GAD: Neuroimaging and Clinical Correlates of Response |
|
|
| Recruiting | N/A | 46 | US | Swedish Massage Therapy, Light Touch Therapy | University of Utah, National Center for Complementary and Integrative Health (NCCIH) | Generalized Anxiety Disorder | 08/25 | 08/25 | | |
| Gordon, Adam J |
VA-BRAVE, NCT04375033: A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder |
|
|
| Recruiting | 4 | 952 | US | Sublingual buprenorphine with naloxone, Injectable subcutaneous buprenorphine | VA Office of Research and Development | Opioid Use Disorder | 09/28 | 05/29 | | |
| Active, not recruiting | N/A | 230 | US | Availability of contextual PGHD at the visit | VA Office of Research and Development, University of Utah | Pain | 09/25 | 09/25 | | |
| Not yet recruiting | N/A | 270 | US | | University of Utah, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Substance Use Disorders (SUD), Pregnancy, Maternal Morbidity and Mortality, Cultural Adaptation | 09/28 | 12/28 | | |
| Polenakovik, Hari |
| Recruiting | 4 | 880 | US | Rifampin, Riboflavin Placebo | VA Office of Research and Development | Osteomyelitis, Diabetes, Amputation | 09/25 | 09/25 | | |
NCT01056185: Respiratory Virus Hospitalization Study (FLU 003 Plus) |
|
|
| Completed | N/A | 1000 | Europe, US, RoW | | University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Clinical & Translational Science Institute, University of Minnesota | Influenza, Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) | 08/24 | 08/24 | | |
| Stehlik, Josef |
NCT05420012: The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation |
|
|
| Completed | 4 | 26 | US | Vericiguat, VERQUVO, Placebo, Control group | Josef Stehlik, Merck Sharp & Dohme LLC | Heart Failure, Heart Failure with Reduced Ejection Fraction (HFrEF) | 10/24 | 10/24 | | |
NCT06625073: Randomized Trial of SGLT2i in Heart Transplant Recipients |
|
|
| Not yet recruiting | 4 | 200 | US | Empagliflozin, Jardiance, Placebo, Control Group | VA Office of Research and Development | Heart Transplant, Cardiovascular Disease, Kidney Disease | 08/29 | 02/30 | | |
| Active, not recruiting | 2 | 385 | US | tocilizumab, Actemra®, Placebo, Placebo for tocilizumab, Placebo for Actemra®, Standard of Care Triple IS, calcineurin inhibitor: (tacrolimus (Prograf ®)), anti-proliferative treatment: (mycophenolate mofetil ),, MMF, CellCept®, Myfortic®, enteric-coated mycophenolate sodium, steroids: methylprednisolone/prednisone | National Institute of Allergy and Infectious Diseases (NIAID), PPD | Heart Transplant | 04/25 | 04/25 | | |
| Withdrawn | N/A | 600 | NA | Prospera Transplant Assessment, Endomyocardial biopsy | Natera, Inc. | Heart Transplant Failure and Rejection | 01/25 | 01/26 | | |
ACES-EMB, NCT06414603: A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy |
|
|
| Recruiting | N/A | 250 | US | The Prosperaâ„¢ Test | Natera, Inc. | Heart Transplant Failure and Rejection | 12/24 | 12/25 | | |
| Completed | N/A | 208 | US | Remote monitoring and predictive analytics, Sham comparator | VA Office of Research and Development, George E. Wahlen Department of Veterans Affairs Medical Center, Michael E. DeBakey VA Medical Center, VA Palo Alto Health Care System, Malcom Randall VA Medical Center, Hunter Holmes McGuire VA Medical Center, VHA Innovation Ecosystem | Heart Failure | 08/24 | 10/24 | | |
NCT02670408: Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation |
|
|
| Recruiting | N/A | 900 | Europe, Canada, US, RoW | Endomyocardial biopsy | University of Alberta | Cardiac Transplant Disorder | 12/25 | 07/26 | | |
| Recruiting | N/A | 300 | Europe, Canada, US, RoW | MMDx diagnostic test, Prospera, HLA antibody | University of Alberta, Natera, Inc., One Lambda | Heart Transplant Rejection | 12/26 | 07/27 | | |
DEFINE-HT, NCT05309382: Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation |
|
|
| Completed | N/A | 147 | US | Prospera | Natera, Inc. | Heart Transplant | 10/24 | 10/24 | | |
IICAPTAIN-HF, NCT06526988: Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure |
|
|
| Not yet recruiting | N/A | 2200 | US | EPIC-HF Patient-facing Tool, PROMPT-HF Clinician-facing Alert | University of Colorado, Denver, Patient-Centered Outcomes Research Institute, Yale University, Northwestern University, University of Utah, Sutter Health | Heart Failure With Reduced Ejection Fraction | 09/28 | 09/28 | | |
NCT01099982: Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease |
|
|
| Recruiting | N/A | 300 | US | | University of Utah, Intermountain Health Care, Inc., VA Salt Lake City Health Care System, Hunter Holmes McGuire VA Medical Center | Congestive Heart Failure | 01/28 | 01/28 | | |
| Richardson, Russell |
| Recruiting | 1 | 420 | US | Maximum Exercise Tests, BH4, L-NMMA, Vitamin C, Vitamin E, α-Lipoic Acid and L-Ascorbate, BQ-123, Fexofenadine, Ranitidine, Allegra, Zantac, Angiotensin-II, Valsartan, Diovan, Acetylcholine, Sodium Nitroprusside, Angiotensin-II, Norepinephrine, Phentolamine, Regitine, BQ-123, MitoQ, BH4 | Russell Richardson | Chronic Obstructive Pulmonary Disease, Pulmonary Artery Hypertension, Heart Failure, Hypertension | 08/25 | 08/25 | | |
NCT03625349: Passive Limb Movement: A Tool to Assess Vascular Health and Guide Rehabilitation |
|
|
| Recruiting | N/A | 130 | US | NG-Monomethyl-L-Arginine, LNMMA | VA Office of Research and Development | Aging, Cardiovascular Disease | 10/25 | 10/25 | | |
| Kondo, Douglas |
NCT03265964: Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation |
|
|
| Completed | 4 | 75 | US | Uridine, Oral Uridine, Placebo, Oral Pill Placebo | VA Office of Research and Development | Suicidal Ideation | 06/24 | 06/24 | | |
| Gawron, Andrew |
NCT04389957: Improving Colonoscopy Quality for Colorectal Cancer Screening in the National VA Healthcare System |
|
|
| Completed | N/A | 500000 | US | | VA Office of Research and Development | Colorectal Neoplasms | 03/24 | 03/24 | | |
| Amann, Markus |
| Recruiting | N/A | 50 | US | Afferent block | VA Office of Research and Development | Heart Failure With Preserved Ejection Fraction | 09/25 | 09/26 | | |
| Burke, Brian |
| Recruiting | 4 | 2510 | US | Pentoxifylline, Placebo | VA Office of Research and Development | Diabetic Kidney Disease | 01/28 | 07/30 | | |
| Trinity, Joel Douglas |
NCT04351113: Targeting Oxidative Stress to Prevent Vascular and Skeletal Muscle Dysfunction During Disuse |
|
|
| Recruiting | N/A | 72 | US | MITO-AO, PB-125, Placebo, Passive Leg Movement (PLM), Plantar flexion, Isometric knee extensor test, Bed rest | Joel Trinity, National Heart, Lung, and Blood Institute (NHLBI) | Aging, Oxidative Stress, Vascular Endothelium, Skeletal Muscle, Antioxidants | 12/25 | 12/25 | | |
| Recruiting | N/A | 300 | US | Mitoquinone, MitoQ, Placebo | VA Office of Research and Development | Long-COVID | 10/27 | 10/28 | | |
| Johnson, Jessica |
| Active, not recruiting | 3 | 505 | Europe, Canada, Japan, US, RoW | VAY736, Placebo | Novartis Pharmaceuticals, Novartis Pharma AG | Sjogren Syndrome | 05/25 | 05/27 | | |
CAPTIVA, NCT05047172: Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis |
|
|
| Recruiting | 3 | 1683 | US | Ticagrelor + Aspirin, Brilinta, Rivaroxaban + Aspirin, Xarelto, Clopidogrel + Aspirin, Plavix, Risk Factor Management | University of Florida, National Institute of Neurological Disorders and Stroke (NINDS), University of Cincinnati, Medical University of South Carolina, Janssen Scientific Affairs, LLC, AstraZeneca | Intracranial Arteriosclerosis, Stroke | 05/28 | 05/28 | | |
MTLE, NCT05135091: FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy |
|
|
| Recruiting | 1/2 | 40 | US | NRTX-1001, GABA-secreting interneurons, Sham Comparator | Neurona Therapeutics, California Institute for Regenerative Medicine (CIRM) | Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis | 05/25 | 05/26 | | |
NCT02844465: Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate) |
|
|
| Completed | N/A | 167 | US | Visualase MRI-Guided Laser Ablation, Visualase System, Visualase procedure, Laser interstitial thermal therapy, Stereotactic laser ablation | MedtronicNeuro | Temporal Lobe Epilepsy | 12/23 | 12/23 | | |
| Active, not recruiting | N/A | 391 | US | MyPath Web-Based Informational and Decision Support Tool | VA Office of Research and Development, Kaiser Permanente, University of California, San Francisco | Contraception, Contraception Behavior, Prepregnancy Health, Reproductive Health | 08/24 | 09/25 | | |
| Recruiting | N/A | 8 | US | Low Frequency Stimulation (LFS) of site with the Medtronic Percept PC system, Standard of Care (SOC) High Frequency Stimulation of the Anterior Nucleus of the Thalamus (ANT) with the Medtronic Percept PC system | Nitin Tandon, National Institute of Neurological Disorders and Stroke (NINDS) | Mesial Temporal Lobe Epilepsy | 03/28 | 03/28 | | |
| Wray, David W |
| Recruiting | 1 | 140 | US | Antioxidant, Tetrahydrobiopterin (BH4), Kuvan, Exercise training | VA Office of Research and Development, University of Utah | Heart Failure With Reduced Ejection Fraction | 05/25 | 05/26 | | |
| Brooke, Benjamin |
| Recruiting | N/A | 400 | US | Transitional Pain Service | VA Office of Research and Development | Chronic Opioid Use | 01/26 | 01/27 | | |
| Active, not recruiting | N/A | 260 | Europe, Canada, US, RoW | JETi Peripheral Thrombectomy System | Abbott Medical Devices | Peripheral Artery Thrombosis, Peripheral Venous Thrombosis | 08/24 | 08/25 | | |
| Recruiting | N/A | 1100 | US | TEVAR, Guideline directed medical therapy and surveillance of dissection | Duke University, The University of Texas Health Science Center, Houston, State University of New York - Downstate Medical Center, Oregon Health and Science University, National Heart, Lung, and Blood Institute (NHLBI) | Type B Aortic Dissection | 06/30 | 06/30 | | |
| Klimas, Nancy |
NCT06211062: The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome |
|
|
| Recruiting | 2 | 100 | US | Floradapt Intensive GI, i3.1, Placebo | Nova Southeastern University | ME/CFS, IBS - Irritable Bowel Syndrome | 01/25 | 12/25 | | |
| Recruiting | 2 | 170 | US | BacoMind® (Bacopa monnieri standardized extract), Bacopa, Bacopa monnieri, Placebo | Nova Southeastern University, RTI International, Boston University | Gulf War Illness | 09/25 | 09/25 | | |
| Recruiting | 2 | 120 | US | Cal-Mag Butyrate, Bodybio Calcium Magnesium Butyrate, Placebo, Placebo Cal-Mag Butyrate | VA Office of Research and Development, Miami VA Healthcare System, VA Salt Lake City Health Care System | Gulf War Illness, Chronic Fatigue, Neurocognitive Dysfunction | 10/25 | 03/26 | | |
NCT04254627: TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset |
|
|
| Recruiting | 1 | 20 | US | Etanercept, Enbrel, Mifepristone, Mifeprex, RU-486 | Nova Southeastern University, RTI International, Miami VA Healthcare System | Gulf War Illness | 09/25 | 09/25 | | |
| Recruiting | 1 | 170 | US | N-Acetyl Cysteine, NAC, Placebo, NAC Placebo | Nova Southeastern University, RTI International, Boston University, Weill Medical College of Cornell University | Gulf War Syndrome | 09/25 | 09/25 | | |
| Recruiting | N/A | 52 | US | Nicotinamide Riboside, Placebo | Roskamp Institute Inc., United States Department of Defense, Nova Southeastern University | Gulf War Illness | 02/25 | 02/25 | | |
| Butler, Jorie |
| Active, not recruiting | N/A | 230 | US | Availability of contextual PGHD at the visit | VA Office of Research and Development, University of Utah | Pain | 09/25 | 09/25 | | |
| DuVall, Scott L |
| Completed | N/A | 5814 | US | Evusheld | AstraZeneca, VA Informatics and Computing Infrastructure (VINCI) | SARS-CoV-2, COVID-19 | 09/23 | 09/23 | | |
| Beddhu, Srinivasan |
| Recruiting | 4 | 2510 | US | Pentoxifylline, Placebo | VA Office of Research and Development | Diabetic Kidney Disease | 01/28 | 07/30 | | |
NCT05173714: Sit Less, Interact and Move More (SLIMM) 2 Study |
|
|
| Recruiting | 2 | 156 | US | SLIMM, Standard Resistance Training, Guided Resistance Training, Placebo, Semaglutide | Srinvasan Beddhu, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Stanford University | Chronic Kidney Diseases, Obesity | 12/26 | 03/27 | | |
| RODRIGUEZ, Leonardo |
VA-BRAVE, NCT04375033: A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder |
|
|
| Recruiting | 4 | 952 | US | Sublingual buprenorphine with naloxone, Injectable subcutaneous buprenorphine | VA Office of Research and Development | Opioid Use Disorder | 09/28 | 05/29 | | |
| Recruiting | N/A | 40 | RoW | RF Vapor Ablation | Aqua Medical, Inc. | Diabetes Mellitus Type 2 | 01/26 | 06/26 | | |
STEAM-IE, NCT06655740: Safety, Tolerability, and Effectiveness of Duodenal Mucosal RF Vapor Ablation for Insulin Elimination in Type-2 Diabetes |
|
|
| Recruiting | N/A | 16 | RoW | RF Vapor Ablation | Aqua Medical, Inc. | Diabetes Mellitus, Type 2 | 03/25 | 07/25 | | |
NCT06724822: RF Vapor Ablation Retreatment of Duodenal Mucosa in Non-responders With Type-2 Diabetes Mellitus |
|
|
| Enrolling by invitation | N/A | 12 | RoW | RF Vapor Ablation | Aqua Medical, Inc. | Diabetes Mellitus, Type 2 | 06/25 | 10/25 | | |
| Larsen, Clint |
| Recruiting | 4 | 880 | US | Rifampin, Riboflavin Placebo | VA Office of Research and Development | Osteomyelitis, Diabetes, Amputation | 09/25 | 09/25 | | |
| Meyer, Laurence J |
NCT03958786: Frailty in People Living With HIV Aged 70 Years or More |
|
|
| Active, not recruiting | N/A | 512 | Europe | Simplified Geriatric Evaluation, Sampling | ANRS, Emerging Infectious Diseases | HIV Infections | 06/21 | 06/24 | | |
| Recruiting | N/A | 300 | Europe | blood sampling | ANRS, Emerging Infectious Diseases | HIV Infection | 09/22 | 09/23 | | |
| Recruiting | N/A | 2800 | Europe | blood sampling | ANRS, Emerging Infectious Diseases | HIV-1-infection | 09/24 | 09/25 | | |
| Schmalfuss, Carsten |
| Active, not recruiting | 4 | 2476 | US | High dose potent statin, atorvastatin or rosuvastatin, ACE-I (lisinopril) or ARB (losartan), ACE-I or ARB, Aspirin, Lifestyle Counseling, PACE Lifestyle Intervention, Quality of Life Questionnaires, QOL | University of Florida, United States Department of Defense | Coronary Artery Disease | 09/24 | 12/24 | | |
| Recruiting | 4 | 7410 | US | Metformin XR, Placebo | VA Office of Research and Development | Prediabetic State, Atherosclerosis, Metformin | 03/29 | 03/29 | | |
| Completed | N/A | 208 | US | Remote monitoring and predictive analytics, Sham comparator | VA Office of Research and Development, George E. Wahlen Department of Veterans Affairs Medical Center, Michael E. DeBakey VA Medical Center, VA Palo Alto Health Care System, Malcom Randall VA Medical Center, Hunter Holmes McGuire VA Medical Center, VHA Innovation Ecosystem | Heart Failure | 08/24 | 10/24 | | |
| Romesser, Jennifer |
| Recruiting | 3 | 774 | US | Trazodone, Eszopiclone, Placebo | VA Office of Research and Development | Insomnia | 02/26 | 02/26 | | |
| Completed | N/A | 426 | US | Prolonged Exposure Therapy, Cognitive Processing Therapy, Present Centered Therapy | Center for Veterans Research and Education, Patient-Centered Outcomes Research Institute, Minneapolis Veterans Affairs Medical Center | Stress Disorders, Post-Traumatic, Substance Use Disorders | 04/24 | 04/24 | | |
| Recruiting | N/A | 360 | US | Stellate Ganglion Block, SGB or Regional Block, Sham Stellate Ganglion Block, Sham SGB | VA Office of Research and Development, Analydata, Inc | Post-traumatic Stress Disorder | 03/25 | 03/26 | | |
| Lui, Charles |
| Recruiting | 4 | 7410 | US | Metformin XR, Placebo | VA Office of Research and Development | Prediabetic State, Atherosclerosis, Metformin | 03/29 | 03/29 | | |
| Sam, Colleen |
| Recruiting | 4 | 7410 | US | Metformin XR, Placebo | VA Office of Research and Development | Prediabetic State, Atherosclerosis, Metformin | 03/29 | 03/29 | | |
| Sripada, Rebecca Kaufman |
| Active, not recruiting | 4 | 700 | US | Selective serotonin reuptake inhibitor, Serotonin-norepinephrine reuptake inhibitor, Written Exposure Therapy | University of Washington, Stanford University, Boston University, Washington State University, Patient-Centered Outcomes Research Institute | PTSD | 08/24 | 12/25 | | |
| Recruiting | N/A | 270 | US | Modified A-B-C: Working with Events, Thoughts, and Feelings, Challenging Questions, Patterns of Problematic Thinking, Challenging Beliefs, Veteran's choice of Module (Safety/Trust/Power and Control/Esteem/Intimacy) | VA Office of Research and Development | Stress Disorders, Post-Traumatic | 07/25 | 03/26 | | |
NCT05751473: Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers |
|
|
| Recruiting | N/A | 410 | US | Prolonged Exposure for Primary Care (PE-PC), EAP Treatment as Usual (TAU) | University of Michigan, National Institute of Mental Health (NIMH) | Post Traumatic Stress Disorder | 08/26 | 08/26 | | |
| Reese, Van R |
NCT03625349: Passive Limb Movement: A Tool to Assess Vascular Health and Guide Rehabilitation |
|
|
| Recruiting | N/A | 130 | US | NG-Monomethyl-L-Arginine, LNMMA | VA Office of Research and Development | Aging, Cardiovascular Disease | 10/25 | 10/25 | | |
| Vallanat, Christopher |
VA-BRAVE, NCT04375033: A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder |
|
|
| Recruiting | 4 | 952 | US | Sublingual buprenorphine with naloxone, Injectable subcutaneous buprenorphine | VA Office of Research and Development | Opioid Use Disorder | 09/28 | 05/29 | | |
| Seppi, Misti R |
| Recruiting | N/A | 50 | US | Afferent block | VA Office of Research and Development | Heart Failure With Preserved Ejection Fraction | 09/25 | 09/26 | | |
| Bachus, Kent N |
| Withdrawn | 1 | 10 | US | PODS | VA Office of Research and Development | Transhumeral Amputation | 01/24 | 01/24 | | |
| Adler, Robert A |
| Completed | N/A | 39 | US | Bone Health Service Model | VA Office of Research and Development | Osteoporosis, Osteopenia, Osteoporotic Fracture | 08/24 | 12/24 | | |
| Kurdgelashvili, George |
| Recruiting | 4 | 880 | US | Rifampin, Riboflavin Placebo | VA Office of Research and Development | Osteomyelitis, Diabetes, Amputation | 09/25 | 09/25 | | |
| Completed | 4 | 308 | US | Fidaxomicin, Vancomycin with Taper/Pulse, Vancomycin | VA Office of Research and Development | Clostridium, Difficile, Fidaxomicin, Vancomycin | 08/24 | 08/24 | | |
| Recruiting | 3 | 852 | Europe, Canada, US, RoW | VE303, Placebo | Vedanta Biosciences, Inc. | Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, CDI, C. Diff Infection, Recurrent Clostridium Difficile Infection, C.Difficile Diarrhea, Diarrhea Infectious | 06/27 | 10/27 | | |
| Swasey, Scott |
| Recruiting | N/A | 2529 | US | Pain EASE, Tailored exercise, Continued Care and Active Monitoring, Cognitive Behavioral Therapy (CBT), Spinal Manipulation Therapy (SMT), Yoga | VA Office of Research and Development | Chronic Low Back Pain | 06/25 | 06/26 | | |
| Gawron, Lori |
NCT06162611: Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo |
|
|
| Recruiting | 4 | 790 | US | Etonogestrel implant with Oral Levonorgestrel emergency contraception 1.5mg, Etonogestrel implant with oral placebo | Lori Gawron, Planned Parenthood Association of Utah | Emergency Contraception | 01/28 | 05/28 | | |
| Completed | 1 | 40 | US | ENG implant, Nexplanon, oral ulipristal acetate, Ella | University of Utah, Merck Sharp & Dohme LLC | Contraception | 10/22 | 01/24 | | |
NCT04143659: A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception |
|
|
| Recruiting | 1 | 136 | US | levonorgestrel butanoate (LB) injection | Health Decisions, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Healthy Women, Female Contraception | 09/24 | 09/24 | | |
| Active, not recruiting | N/A | 297 | US | | University of Utah | Contraception | 05/23 | 01/25 | | |
| Active, not recruiting | N/A | 391 | US | MyPath Web-Based Informational and Decision Support Tool | VA Office of Research and Development, Kaiser Permanente, University of California, San Francisco | Contraception, Contraception Behavior, Prepregnancy Health, Reproductive Health | 08/24 | 09/25 | | |
NCT05610527: Hormonal Influences on Inflammatory Bowel Diseases |
|
|
| Not yet recruiting | N/A | 200 | US | Proposed study design and randomization scenarios, Repeated measures of validated Inflammatory Bowel Disease Patient Reported Outcome Instruments, UC PRO Instrument, Crohn's PRO Instrument, Inflammatory marker collection and assessment for correlation with PRO responses and menstrual timing, Inflammatory markers | University of Utah | Inflammatory Bowel Diseases, Contraception, Menstrual Problem | 08/26 | 03/27 | | |
| Bauer, Michelle |
VA-BRAVE, NCT04375033: A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder |
|
|
| Recruiting | 4 | 952 | US | Sublingual buprenorphine with naloxone, Injectable subcutaneous buprenorphine | VA Office of Research and Development | Opioid Use Disorder | 09/28 | 05/29 | | |
| Wuthrich, Amyanne |
| Recruiting | N/A | 400 | US | Transitional Pain Service | VA Office of Research and Development | Chronic Opioid Use | 01/26 | 01/27 | | |
| Active, not recruiting | N/A | 230 | US | Availability of contextual PGHD at the visit | VA Office of Research and Development, University of Utah | Pain | 09/25 | 09/25 | | |
| Completed | N/A | 208 | US | Remote monitoring and predictive analytics, Sham comparator | VA Office of Research and Development, George E. Wahlen Department of Veterans Affairs Medical Center, Michael E. DeBakey VA Medical Center, VA Palo Alto Health Care System, Malcom Randall VA Medical Center, Hunter Holmes McGuire VA Medical Center, VHA Innovation Ecosystem | Heart Failure | 08/24 | 10/24 | | |
| Bunsawat, Kanokwan |
| Recruiting | N/A | 35 | US | Exercise training | VA Office of Research and Development | HFpEF | 07/27 | 02/28 | | |
| Brock, Charles |
| Recruiting | N/A | 360 | US | Stellate Ganglion Block, SGB or Regional Block, Sham Stellate Ganglion Block, Sham SGB | VA Office of Research and Development, Analydata, Inc | Post-traumatic Stress Disorder | 03/25 | 03/26 | | |
